Abstract
Aims and ObjectiveTo study the role of myoepithelial (ME) cells in distinguishing benign, proliferative breast diseases (PBD) and frank malignant breast lesions.Materials and methodsIn this study, histology proven 71 cases of fine needle aspiration cytology (FNAC) of palpable breast lesions were selected. There were 30 invasive carcinomas (24 infiltrating duct carcinoma and 6 infiltrating lobular carcinoma), 25 cases of benign lesion (21 fibroadenomas and 4 fibrocystic lesions) and 11 proliferative breast diseases (other than carcinoma in situ) and five cases of carcinoma in situ. The number of ME cells were estimated in respect to 1000 ductal cells. In every case at least 20 high power fields (× 40) were studied. Quantitative estimation of ME cell was correlated with the final diagnosis. Corresponding histopathology cases were also evaluated for diagnostic confirmation along with the pattern of distribution of ME cells. The ME cells were also quantitated on histopathology sections on smooth muscle actin (SMA) immunostained sections.ResultsThe mean number of ME cells per 1000 ductal cells on cytology smears was 5.1 ± 5.5, 30.8 ± 25, 28.3 ± 20.2, and 38.4 ± 38.8 in malignant, carcinoma in situ, PBD and benign breast lesions respectively. The non parametric Mann Whitney test showed significant difference in number of the ME cells between benign and malignant groups (p < .000), PBD and malignant groups (p < .000) and carcinoma in situ and malignant group (p < .001). However, it was insignificant between benign and PBD group, and PBD and carcinoma in situ (p > .01). In SMA stained histopathology sections, ME cell in benign, PBD, carcinoma in situ and malignant cases were 741.12 ± 248, 238 ± 172, 121.6 ± 115 and 15.6 ± 25.1 respectively. Statistical analysis showed significantly different number of ME cell between benign versus PBD group, carcinoma in situ and malignant group. It was also significant between PBD versus malignant, and carcinoma in situ versus malignant (p < .001, Mann Whitney test). However number of ME cell was not significant between PBD versus carcinoma in situ.ConclusionThe number of ME cell in breast lesions may be helpful in distinguishing PBD versus invasive malignant tumors on FNAC smears. However it is not helpful to distinguish benign lesions versus PBD.
Highlights
Fine needle aspiration cytology (FNAC) is an important tool for rapid and accurate diagnosis of various benign and malignant breast lesions with high sensitivity and specificity [1,2,3,4]
Statistical analysis showed significantly different number of myoepithelial cell (ME) cell between benign versus proliferative breast diseases (PBD) group, carcinoma in situ and malignant group. It was significant between PBD versus malignant, and carcinoma in situ versus malignant (p < .001, Mann Whitney test)
The number of ME cell in breast lesions may be helpful in distinguishing PBD versus invasive malignant tumors on FNAC smears
Summary
Fine needle aspiration cytology (FNAC) is an important tool for rapid and accurate diagnosis of various benign and malignant breast lesions with high sensitivity and specificity [1,2,3,4]. In certain occasion it is difficult to provide a definitive diagnosis in breast neoplasm with the help of FNAC. This is true in proliferative breast diseases (PBD), and certain types of carcinomas such as tubular carcinoma and lobular carcinomas [5,6,7]. Its presence in proliferative breast diseases has rarely been explored in FNAC smears [8,9,10,11] In this present paper we studied the role of quantitation of ME cells in distinguishing benign, PBD and frank malignant breast lesions
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
